HyperandrogenismHyperandrogenism Dr. Mona Shroff SOGOG CME 2007.

Slides:



Advertisements
Similar presentations
  LONG TERM WEIGHT MANAGEMENT TO PROMOTE REPRODUCTIVE HEALTH IN OVER WEIGHT/OBEASE WOMEN WITH POLYCYSTIC OVARIAN SYNDROME.   DR.PREMA.H.S,
Advertisements

CASE PRESENTATION (4)(6)(7)
Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome (PCOS)
Infertility and PCOS Erinn Myers, M4 Department of Obstetrics and Gynecology University of Tennessee Health Science Center January 28, 2007.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
IN THE NAME OF GOD Elham Faghihimani endocrinologist.
Valerie Robinson, DO. Polycystic Ovarian Syndrome (PCOS) is a disorder that causes menstrual and ovulation irregularities, androgen excess, and infertility.
© Copyright Annals of Internal Medicine, 2011 Ann Int Med. 154 (3): ITC2-1. Terms of Use  The In the Clinic ® slide sets are owned and copyrighted by.
HYPERANDROGENISM, HIRSUTISM AND POLYCYSTIC OVARY SYNDROME
Polycystic ovarian syndrome
PCOS Polycystic Ovary Syndrome
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Insulin sensitizing agents use in pregnancy and as therapy in PCOS
General Medicine Conference “Hirsutism” General Medicine Conference “Hirsutism” Selim Krim, MD Assistant professor Texas Tech University Health Sciences.
Current Concepts in Polycystic Ovarian Syndrome Mark N. Simon, MD Exempla Uptown Women’s Healthcare Specialists October 17, 2003.
Diane 35 safety concerns BY: MOHAMMED ALSAIDAN.
Polycystic Ovary Syndrome Krishna B. Singh, MD Department of Obstetrics & Gynecology LSU Health Sciences Center Shreveport, LA.
HDR Women’s Health 11 th April 2012 By Dr Mahya Mirfattahi GP ST3 POLYCYSTIC OVARY SYNDROME A SUMMARY OF RCOG GREEN-TOP GUIDELINE.
Hyperandrogenism Dr. Mona Shroff
HIRSUTISM. Definition  Hirsutism Excessive growth of hair in abnormal position on the body  Virilism Masculinization of female i.e. deepening of voice,
Polycystic Ovary Syndrome
Polycystic Ovary Syndrome Jamal Zaidi Consultant Obstetrician & Gynaecologist East Sussex Healthcare NHS Trust.
Christopher R. Graber, MD Salina Women’s Clinic 10 Dec 2010.
EXCESSIVE HAIR GROWTH HIRSUTISM VIRILIZATION. Hair type S Hair type S Lanugo : Body hair seen in newborn Vellus : Fine adult hair covering body Terminal.
POLYCYSTIC OVARY SYNDROME A COMMON FEMALE ENDOCRINE DISEASE SBI4U-01 Mr. Gajewski Bashour Yazji Jason Antrobus Narayan Wagle.
SEX HORMONE THERAPY Anti-progestogens Mifiproston RU 486 : 19 nor testosterone derivative with different side chains. It has strong affinity for progestogen.
DR.ABHISHEK SINGH PARIHAR M.S (Obs & Gyne) ; FELLOW REPRODUCTIVE MEDICINE CONSULTANT : LIFECARE IVF CENTRE, NEW DELHI ABALONE CLINIC, NOIDA ETERNA IVF.
Polycystic Ovarian Disorder Max Brinsmead MB BS PhD August 2014.
Hirsutism & Virilization Assoc. Prof. Gazi YILDIRIM, M.D. Yeditepe University, Medical Faculty Dept of Ob&Gyn.
Amenorrhea Dr Nadia algantary Associated proffessor Faculty of medicine.
ANOVULATION CEM FICICIOGLU, M.D, Ph.D.,AA.,MBA.
Pathogenesis (etiology?) Hypersecretion of adrenal androgens? Hypersecretion of ovarian androgens? A genetic disorder with an autosomal dominant mode.
Investigating infertile couple
Please Be Sure You Have An Audience-Response Device (Clicker)
Abnormal Uterine Bleeding Case Studies. VETERANS HEALTH ADMINISTRATION Abigail, a 24-year-old female, presents to your office complaining that her menstrual.
PROFESSOR ZEINAB ABOTALIB Consultant Obstetrics & Gynaecology and infertility.
Investigations of infertility
Dr. ASMAA A. AL SANJARY. The student at the end of this lecture should be able to: Enumerate the diagnostic criteria for PCOS. Describe it’s clinical.
Hirsutism Andrew Rodin 1st March 2016.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Endocrine disorders in the infancy and childhood Éva Erhardt MD, PhD.
Polycystic Ovarian Syndrome Lindsay White. Polycystic Ovarian Syndrome (PCOS) is the most common cause of female infertility.
Case Presentation LM – 11/2011. Presenting Complaint Current age - 3 Yr 11 mth ♀ Premature pubarche First noticed between 18 mth and 2yr Progressive.
Dr. ASMAA A. AL SANJARY. The student at the end of this lecture should be able to : Differentiate the hirsutism from virilisim. Determine the severity.
AHMED ABDULWAHAB COSULTANT ASSISTANT PROFESSOR. It is increase growth of hair in women in a distribution to that similar to male. It should not be confused.
How Does Body Maintain Normal Blood Sugar? a Insulin Resistance and Its Consequences Sidika E. Karakas, M.D Professor and Chief Division of Endocrinology,
Hirsutism Max Brinsmead MB BS PhD July Definition of Hirsutism  Terminal hairs in a female (or child) in a male pattern distribution and amount.
Hyperandrogenism in the adolescent girl Dr. Mona Shroff, M.D. Diploma in Obs. & Gynaec Ultrasound EMOC Clinical Trainer (JHPIEGO)
Hyperprolactinaemia. Introduction.  Prolactine (PRL) is secreted from the Anterior Hypophisis.  Normal blood level of PRL: IU/L or 12.5 – 25.
PCOS: Polycystic Ovarian Syndrome
Traveling CME Daniel Preud’Homme, MD, FACN, FAAP
POLYCYSTIC OVARY SYNDROME
IN THE NAME OF GOD.
Paola Palma Sisto, MD Pediatric Endocrinology
Polycystic Ovarian Syndrome
Polycystic Ovary Disease
GLYPICAN-4 LEVELS IN RELATION WITH HORMONAL AND METABOLIC PROFILE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME Doç.Dr.Özlem ALTINKAYA.
Hyperprolactinemia Is the elevation of prolactine hormone which is secreted from anterior pituitary gland.
Orquidia Torres, MD Division of Adolescent and Young Adult Medicine
Polycystic ovarian syndrome Obesity and Insulin resistance
Biomarkers of ovarian cancer and cysts
Biomarkers of ovarian cancer and cysts
Hirsutism & Virilization
CEM FICICIOGLU, M.D, Ph.D.,AA.,MBA
Polycystic ovary syndrome (PCOS) is extremely prevalent and probably constitutes the most frequently encountered endocrine (hormone) disorder in women.
HIRSUTISM Dr. Maysa’khadra MBBS, MMed(RHHG)
Presentation transcript:

HyperandrogenismHyperandrogenism Dr. Mona Shroff SOGOG CME 2007

Case A 14 y/o female (menarche 1 yr back) Menses q 3--4 months Mild facial acne FG Score of 5 (1 lip, 1 chin, 2 lower abd, 1 back) BMI 29 kg/m2 No galactorrhoea

What are the various causes of hyperandrogenism? In this adolescent girl what probable cause do you suspect?

Aetiology of hyperandrogenism FOH of puberty PCOS HAIR-AN syndrome Hyperprolactinemia Hypothyroidism NCAH TUMORS-Ovarian / Adrenal Cushings disease Drugs

What particular aspects of history & clinical features would you like to look for?

Clinical assessment History The following items are important:: Family History of HA/Obesity/temporal balding/infertility Hx of Precocious adrenarche More than 2 years of oligomenorrhea

Clinical assessment.. Physical examination Degree of hirsutism, acne Obesity,increased W/H ratio Acanthosis nigricans- r/o PCOS,HAIR-AN Rapidly growing hirsutism or Virilizing symptoms – r/o TUMOR Symptoms of hypercorticism –r/o CUSHING Galactorrhea – r/o HYPERPROLACTINEMIA

What is this C/F?

Would you like to investigate this patient at this juncture?

Would you like to start treatment at this time? In which particular patients would you evaluate & treat at an early age?

J Pediatr Jan;144(1):23-9. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome in a high-risk group of formerly LBW girls.

LIFESTYLE MODIFICATIONS

Adult v/s Adolescent HA FOH or Organic cause??? USG not reliable-ovaries may be N. Premature adrenarche –strong predictor. Lifestyle changes – biggest impact-Prevention of PCOD !!! J Pediatr Endocrinol Metab. 2000;13 Suppl 5:

Same patient comes to you after 2 yrs (age 16 yrs) - still having same clinical picture but worsened delayed periods mod. acne & hirsutism BMI 32

Would you like to evaluate this patient now? What initial screening investigations would you like to go for & why?

INITIAL LAB SCREENING TESTOSTERONE PROACTIN TSH Evaluation for HYPERINSULINEMIA 17 OH PROGESTERONE

INITIAL LAB SCREENING Testosterone total – may be N in hirsute woman if T> 200 screen for tumor free T?? Should we ask for? – no clinical need to check - if HA effect seen then free T must be raised - does not help in D/D or treatment

TSH - esp if alopecia PROLACTIN - DHEAS,free T (SHBG ) HYPERINSULINEMIA Fasting glucose : Insulin < 4.5 Fasting insulin > 20 2 hr GTT > 140

17 OH P - for NCAH, follicular ph/morning -routine screen in HA indicated (esp if sev hirsutism at younger age,short stature) * <200 ng/dl : N * 200 – 800 : ACTH stimulation test * > 800 : diagnostic

Screen for Cushings if clinical suspicion late eve. plasma cortisol single dose overnight DST Imaging of adrenals & ovaries (USG/CT/MRI) * if rapid virilization * T > 200 micgm/ dl

Audience question Would you like to include S.DHEAS in her list of investigations? If YES - WHY? If NO – WHY NOT?

DHEAS ??? Moderate elevation common in anovulatory females > 700 micgm/dl – v.rare if T> 200 – screen for tumor must Mod. elevated DHEAS does not necessitate or prove the need & benefit of treatment with dexamethasone No further benefit by testing,not cost effective Gordon,Speroff 2002

Lab results of this patient TSH, Prolactin, 17OH P : normal Total T : 70 ng/mL [<72 ng/mL] Fasting Insulin : 22 mIU/mL [<20 mIU/mL] Fasting Glucose 92 mg/dL

What are the options available for treating HA?

COCPs ANTIANDROGENS SPIRONOLACTONE FUTAMIDE FINASTERIDE CYPROTERONE DEXAMETHASONE KETOCONAZOLE CIMETEDINE GnRH AGONISTS INSULIN SENSITIZERS MECHANICAL AGENTS(hirsutism) ANTIBIOTICS (acne)

Considering our diagnosis of PCOS in this girl what are your aims of treatment What treatment would you like to start in this patient? How long should you continue with this treatment?

Management of excess ovarian androgen production : Standard therapy is :combined E+P OCs It reduces ovarian androgen production It increases SHBG It induces competition at the cellular level for binding to the androgen receptor

METFORMIN In addition to the expected improvements in insulin sensitivity and glucose metabolism Ameliorates hyperandrogenism and menstrual irregularity. Reduces total cholesterol, LDL and triglycerides of PCOS adolescents while increasing HDL cholesterol. Decrease C-reactive protein and a normalization of the neutrophil/lymphocyte ratio, which are predictive of cardiovascular disease. Benefits both obese & non obese Hum Reprod Sep;20(9): Hum Reprod Jul;17(7):

ANTIANDROGENS According to currenty available evidence no antiandrogen is superior to other in terms of clinical efficacy, so choice depends upon S/E & cost.Further studies needed. Chocrane reviews, Issue 1, 2006 Fertil Steril. 1999Mar;71(3): –

S/E & cost of antiandrogens drugS/ECost/mnth(Rs) spironolactoneMetrorrhagia,K G.I,drowsiness Finasteridemild flutamideG.I, Liver750 Cyproterone acetate As with COCPs KetoconazoleG.I, Liver

Would you like to add a steroid (dexona) to your therapy in this patient?

AUDIENCE QUESTION WHICH PILL WOULD YOU CHOOSE FOR ADOLESCENT PCOS with HA & WHY? LNG containing (mala-D,ovral-L,Loette) DESOGESTREL containing (novelon,femilon) CYPROTERONE containing (Ginette,krimson35, diane35) DROSPIRINONE containing (yasmin)

COCs LNG vs Desogestrel vs CPA DSG & CPA pills comparable efficacy, better than LNG.(CPA slightly better for acne) DSG & CPA pills comparable side effects ( VENOUS THROMBOEMBOLISM & LIVER ) Acta Obstet Gynecol Scand Suppl. 1986;134: Int J Fertil Menopausal Stud Jul-Aug;41(4): Fertil Steril May;77(5): Eur J Contracept Reprod Health Care Mar;6(1): J Obstet Gynaecol Can Dec;25(12): Pharmacoepidemiol Drug Saf Jul;13(7): Pharmacoepidemiol Drug Saf Oct-Nov;12(7):

Case B 16 y/o female Menses q 3-4 months Moderate facial acne FG Score of 5 (1 lip, 1 chin, 2 lower abd, 1 back) Tanner Stage breast 4, pubic hair 4 BMI kg/m2 No galactorrhoea INITIAL SCREENING ??

Lab results TSH,, Prolactin normal 17OH P : 2.5 ng/mL [<2 ng/mL] Total T : 70 ng/mL [<72 ng/mL] Fasting Insulin 14 mIU/mL [<17 mIU/mL] Fasting Glucose 92 mg/dL What would you do next?

ACTH Stimulation Test Baseline 17 OH P 2..5 ng/dL 60 min 17 OH P 18 ng/dL What is your inference? How would you treat this patient?

Treat hyperandrogenism with dexamethasone or CPA or spironolactone or flutamide Treat irregular menses with combined oral contraceptive pills Treat infertility when patient desires pregnancy Consider adding dexamethasone to ovulation induction

NCAH J Clin Endocrinol Metab Mar;70(3): Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. Peripheral antiandrogen therapy may be more appropriate in late-onset adrenal hyperplasia patients than conventional adrenal inhibition using cortisone therapy.

CONCLUSIONS HA is a common adolescent probem Our main aim is early PCOS diagnosis & ruling out tumor/NCAH. Watch for premature pubarche. Initial screen –T, TSH, Prolactin, fasting glucose:insulin, 17 OH P Imaging for tumor if T>200 or rapid virilisation

CONCLUSIONS (contd.) Lifestye modification & weight reduction plays a key role. Integrated approach – combination of drugs with best outcome & min. S/E. (COCs + IS +/- Antiandrogen). PCOS - Candidates for long term therapy.

THANK YOU